InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Alkon Daniel L., Directeur Scientifique. Officer active across 1 companies, notably Synaptogenix, Inc.. Cumulatively, 4 filings have been logged. Total volume traded: €136k. The latest transaction was filed on 13 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
080,000 shares0
Common Stock, par value $0.0001 per share
SEC:0001104659-21-092713·
080,000 shares0
Common Stock, par value $0.0001 per share
SEC:0001104659-21-092713:0·
€68,13910,000 shares@ €6.8139100.0% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-21-081898·
Ideal exit: 11 Mar 2022 (T+270)
€68,13910,000 shares@ €6.813950.0% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-21-081898:0·
Ideal exit: 11 Mar 2022 (T+270)
4 of 4 declarations
About Alkon Daniel L.
Daniel L. Alkon serves as Chief Scientific Officer at Synaptogenix, Inc. He is responsible for leading the company's scientific and research initiatives, contributing to innovation and the development of new treatments. His scientific expertise is crucial for Synaptogenix's success.
